Skip to main content
. 2022 Jun 11;22:340. doi: 10.1186/s12887-022-03400-4

Table 2.

Viral suppression at enrolment compared to 48 weeks, among those with both valid results

VL at 48 weeks (copies/mL)
 < 1000  ≥ 1000 Total
VL at enrolment (copies/mL)  < 1000 150 (47.9%) 27 (8.6%) 177 (56.5%)
 ≥ 1000 49 (15.7%) 87 (27.8%) 136 (43.5%)
Total 199 (63.6%) 114 (36.4%) 313 (100%)